New Retina Radio by Eyetube

Un pódcast de Eyetube

191 Episodo

Rates of Ocular AEs After Faricimab Injection
Publicado: 21/3/2025
Treating Geographic Atrophy (GA) In Your Practice
Publicado: 5/3/2025
Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy
Publicado: 5/3/2025
Using OCT Angiography to Distinguish RVO and RAO
Publicado: 9/1/2025
OCT Angiography in a Real-world CSR Case
Publicado: 9/1/2025
Switching from Aflibercept to Faricimab in Wet AMD Patients
Publicado: 19/12/2024
GA Options in Clinical Therapy: Which Patients Are a Fit for GA Treatment?
Publicado: 12/12/2024
AAO '24: Real-world PDR Treatment vs. Protocol S Guidelines, and Retinal Imaging for Alzheimer's
Publicado: 5/12/2024
New Retina Radio Journal Club w/ VBS: Does Metformin Reduce AMD Risk?
Publicado: 21/11/2024
AAO '24 Late-Breakers: Preventing Fas Activation Prior to RRD Repair, and Phase 2/3 Data on an Oral Therapy for GA
Publicado: 14/11/2024
AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD
Publicado: 7/11/2024
AAO '24: COVID and Retinal Disease, Plus the Latest on Step Therapy and Declining Reimbursement
Publicado: 31/10/2024
GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?
Publicado: 28/10/2024
New Retina Radio Journal Club with VBS: Pre-treatment with Chlorhexidine vs. Povidone-Iodine in Endophthalmitis Prevention
Publicado: 17/10/2024
Real-World Studies Reported in Lisbon: Untreated GA Progression and High-Dose Aflibercept in Wet AMD, DME, and DR
Publicado: 9/10/2024
New Retina Radio Journal Club w/ VBS: Risk of Death, Stroke, and MI After RAO
Publicado: 17/9/2024
ASRS ’24: C1q Inhibition and Metformin for AMD
Publicado: 5/9/2024
New Retina Radio Journal Club with VBS: Switching to Faricimab in Wet AMD Patients With a History of Anti-VEGF Therapy
Publicado: 29/8/2024
ASRS ’24: PAVILION at 100 Weeks
Publicado: 22/8/2024
ASRS ’24: ACP in Patients with Major EZ Attenuation, and GALE Microperimetry Findings
Publicado: 8/8/2024

1 / 10

New Retina Radio is a place to hear stories about retina that are told nowhere else.

Visit the podcast's native language site

191 Episodo

Rates of Ocular AEs After Faricimab Injection

Treating Geographic Atrophy (GA) In Your Practice

Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy

Using OCT Angiography to Distinguish RVO and RAO

OCT Angiography in a Real-world CSR Case

Switching from Aflibercept to Faricimab in Wet AMD Patients

GA Options in Clinical Therapy: Which Patients Are a Fit for GA Treatment?

AAO '24: Real-world PDR Treatment vs. Protocol S Guidelines, and Retinal Imaging for Alzheimer's

New Retina Radio Journal Club w/ VBS: Does Metformin Reduce AMD Risk?

AAO '24 Late-Breakers: Preventing Fas Activation Prior to RRD Repair, and Phase 2/3 Data on an Oral Therapy for GA

AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD

AAO '24: COVID and Retinal Disease, Plus the Latest on Step Therapy and Declining Reimbursement

GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?

New Retina Radio Journal Club with VBS: Pre-treatment with Chlorhexidine vs. Povidone-Iodine in Endophthalmitis Prevention

Real-World Studies Reported in Lisbon: Untreated GA Progression and High-Dose Aflibercept in Wet AMD, DME, and DR

New Retina Radio Journal Club w/ VBS: Risk of Death, Stroke, and MI After RAO

ASRS ’24: C1q Inhibition and Metformin for AMD

New Retina Radio Journal Club with VBS: Switching to Faricimab in Wet AMD Patients With a History of Anti-VEGF Therapy

ASRS ’24: PAVILION at 100 Weeks

ASRS ’24: ACP in Patients with Major EZ Attenuation, and GALE Microperimetry Findings